VXRT - Multiplikator Forward P/S Vaxart Corp

Logo korporat perusahaan Vaxart (VXRT)

The key growth driver for Vaxart, Inc. (VXRT) is the VAAST platform for developing tablet-based vaccines against influenza and norovirus. The forward P/S multiple on this GURU.Markets chart reflects the impact of these developments, with the 1.50 mark capturing this metric. The company's advantages are based on simplified immunization logistics and high production scalability, which significantly reduce costs compared to injections.

VXRT (Vaxart) riwayat Kapitalisasi marang prakiraan pendapatan saka 04.07.2022 nganti 19.07.2025

Rincian metrik komprehensif lan analitis vaxart.com (VXRT)

- rega saham lan target rega konsensus:
Kutipan saham Vaxart|VXRT - Bagan rega target
- statistik kapitalisasi pasar:
Kapitalisasi pasar Vaxart, Inc.|VXRT - Nilai Perusahaan
- statistik nilai buku emiten:
Nilai Akuntansi saben Saham Vaxart|VXRT - Kapitalisasi Akuntansi|Rasio Kapitalisasi Pasar marang Nilai Buku vaxart.com|VXRT - Total Aset Perusahaan
- indikator beban kredit lan likuiditas emiten:
Utang marang Ekuitas Vaxart, Inc.|VXRT - Koefisien utang jangka dawa marang modal|Rasio utang jangka cendhak marang ekuitas Vaxart|VXRT - Tanggungan utang kumulatif perusahaan|Utang marang nilai buku Vaxart, Inc.|VXRT - Silihan lan utang jangka dawa perusahaan|Utang jangka cendhak perusahaan Vaxart|Likuiditas cepet vaxart.com
- indikator pendapatan resik lan kelipatan nilai:
VXRT - Bathi perusahaan|Proyeksi bathi mangsa ngarep Vaxart, Inc.|VXRT - Koefisien rega marang bathi|Prakiraan rega marang bathi Vaxart|VXRT - Kapitalisasi marang bathi resik kanthi nimbang wutah|Rasio nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Vaxart, Inc.|VXRT - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi resik saben saham sajrone 12 wulan pungkasan Vaxart|VXRT - Bathi saben saham sajrone 12 wulan pungkasan|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan vaxart.com|VXRT - Tambahing bathi saben saham ing taun lumaku|Prakiraan wutah bathi saben saham kanggo taun ngarep Vaxart, Inc.
- indikator dodolan lan pendapatan:
VXRT - Total dodolan perusahaan|Prakiraan pendapatan perusahaan Vaxart|VXRT - Rasio rega marang dodolan|Multiplikator Forward P/S Vaxart, Inc.
Analisis umum perusahaan:Vaxart Corp (VXRT)
Produk asli Vaxart Inc.

The implementation of robotic molecule screening and automated clinical trial data analysis at Vaxart, Inc. (VXRT) is transforming the structure of future revenues, making the company's modeled P/S ratio a key valuation tool. This indicator correlates current market capitalization with projected revenue, allowing investors to promptly identify asset overbought conditions and determine the fair value of the business between quarterly reports.

Pesaing wigati

Gilead Sciences - Multiplikator forward rega marang pendapatan|Cidara Therapeutics Corp - Rasio rega marang prakiraan pendapatan|Novavax Corp - Multiplikator Forward P/S|CVAC - Multiplikator Forward P/S|VALN (Valneva SE) - Multiplikator forward rega marang pendapatan|Kapitalisasi marang prakiraan pendapatan VIR|SIGA (SIGA Technologies) - Multiplikator Forward P/S|Multiplikator Forward P/S Emergent BioSolutions Inc|Rasio rega marang prakiraan pendapatan Atea Pharmaceuticals Inc (AVIR)|IVVD (invivyd.com) - Rega forward marang dodolan|Enanta Pharmaceuticals - Multiplikator forward rega marang pendapatan|Rasio rega marang pendapatan sing dikarepake INO (inovio.com)|HLVX: Multiplikator forward rega marang pendapatan|Rega forward marang dodolan KLRS (Kalaris Therapeutics Inc.)|DYAI: Multiplikator Forward P/S|NNVC - Rasio kapitalisasi marang dodolan sing dikarepake|Rasio rega marang prakiraan pendapatan Talphera, Inc.|Kapitalisasi marang prakiraan pendapatan COCP (cocrystalpharma.com)|Multiplikator Forward P/S TRAW|Multiplikator forward rega marang pendapatan dwtx.com DWTX|Qualigen - Multiplikator forward rega marang pendapatan|Rasio kapitalisasi marang dodolan sing dikarepake AlloVir Inc (ALVR)|VBIV: Multiplikator forward rega marang pendapatan|VIRI: Rasio rega marang prakiraan pendapatan